292 related articles for article (PubMed ID: 3826892)
1. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
[TBL] [Abstract][Full Text] [Related]
2. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
[TBL] [Abstract][Full Text] [Related]
3. Modulation of alveolar macrophage leukotriene B4 released by complement component C5.
Robbins RA; Gossman GL; Allington LA; Kendall TJ; Stull TW; Rennard SI
J Lab Clin Med; 1990 Apr; 115(4):497-503. PubMed ID: 2157785
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor.
Gadek JE; Hunninghake GW; Zimmerman RL; Crystal RG
Am Rev Respir Dis; 1980 Apr; 121(4):723-33. PubMed ID: 6992662
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of neutrophil recruitment to the lung by grain dust exposure.
Von Essen SG; Robbins RA; Thompson AB; Ertl RF; Linder J; Rennard S
Am Rev Respir Dis; 1988 Oct; 138(4):921-7. PubMed ID: 3059885
[TBL] [Abstract][Full Text] [Related]
6. Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization.
Hunninghake GW; Gadek JE; Fales HM; Crystal RG
J Clin Invest; 1980 Sep; 66(3):473-83. PubMed ID: 6995485
[TBL] [Abstract][Full Text] [Related]
7. Complement fragments, alveolar macrophages, and alveolitis.
Henson PM; McCarthy K; Larsen GL; Webster RO; Giclas PC; Dreisin RB; King TE; Shaw JO
Am J Pathol; 1979 Oct; 97(1):93-110. PubMed ID: 495697
[TBL] [Abstract][Full Text] [Related]
8. Human alveolar macrophages release a factor that inhibits phagocyte function.
Sibille Y; Merrill WW; Naegel GP; Care SB; Cooper JA; Reynolds HY
Am J Respir Cell Mol Biol; 1989 Nov; 1(5):407-16. PubMed ID: 2561589
[TBL] [Abstract][Full Text] [Related]
9. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Martin TR; Raugi G; Merritt TL; Henderson WR
J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.
Ozaki T; Hayashi H; Tani K; Ogushi F; Yasuoka S; Ogura T
Am Rev Respir Dis; 1992 Jan; 145(1):85-91. PubMed ID: 1309969
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
Desai U; Dickey B; Varani J; Kreutzer DL
J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
[TBL] [Abstract][Full Text] [Related]
12. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
Kazmierowski JA; Gallin JI; Reynolds HY
J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
[TBL] [Abstract][Full Text] [Related]
13. Fifth component of complement (C5)-derived high-molecular-weight macrophage chemotactic factor in normal guinea pig serum.
Kukita I; Yamamoto T; Kawaguchi T; Kambara T
Inflammation; 1987 Dec; 11(4):459-79. PubMed ID: 3121506
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.
Hubbard RC; Fells G; Gadek J; Pacholok S; Humes J; Crystal RG
J Clin Invest; 1991 Sep; 88(3):891-7. PubMed ID: 1653278
[TBL] [Abstract][Full Text] [Related]
15. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
[TBL] [Abstract][Full Text] [Related]
17. Time course of chemotactic factor generation and the corresponding macrophage response to asbestos inhalation.
Warheit DB; Hill LH; George G; Brody AR
Am Rev Respir Dis; 1986 Jul; 134(1):128-33. PubMed ID: 3729150
[TBL] [Abstract][Full Text] [Related]
18. In vitro activation of rat neutrophils and alveolar macrophages with IgA and IgG immune complexes. Implications for immune complex-induced lung injury.
Warren JS; Kunkel SL; Johnson KJ; Ward PA
Am J Pathol; 1987 Dec; 129(3):578-88. PubMed ID: 2827492
[TBL] [Abstract][Full Text] [Related]
19. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
Perez HD; Hooper C; Volanakis J; Ueda A
J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
